Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 2,254 |
|
|||||
| News | - | ||||||
| Day High | 2.32 | Low High |
|||||
| Day Low | 2.32 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Harvard Apparatus Regenerative Technology Inc (QB) | HRGN | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.07 | 3.11% | 2.32 | 15:07:51 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.32 | 2.32 | 2.32 | 2.32 | 2.25 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5 | 2,254 | US$ 2.32 | US$ 5,229 | - | 2.13 - 6.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 13:02:25 | 1,250 | US$ 2.32 | USD |
Harvard Apparatus Regenerative Technology Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 32.36M | 13.88M | 7.41M | 103k | -9.02M | -0.65 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Harvard Apparatus Regene... (QB) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/06/2024 | 15:47 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/18/2023 | 16:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/11/2023 | 13:04 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 8/21/2023 | 10:30 | AllPennyStocks.com | Approval of Orphan Disease Application for this Biotech Firm |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HRGN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.46 | 2.46 | 2.25 | 2.30 | 322 | -0.14 | -5.69% |
| 1 Month | 2.51 | 2.96 | 2.14 | 2.53 | 541 | -0.19 | -7.57% |
| 3 Months | 3.40 | 3.80 | 2.13 | 3.29 | 5,020 | -1.08 | -31.76% |
| 6 Months | 5.815 | 5.96 | 2.13 | 3.64 | 3,254 | -3.50 | -60.10% |
| 1 Year | 4.45 | 6.00 | 2.13 | 4.18 | 3,133 | -2.13 | -47.87% |
| 3 Years | 4.45 | 6.00 | 2.13 | 4.18 | 3,133 | -2.13 | -47.87% |
| 5 Years | 4.45 | 6.00 | 2.13 | 4.18 | 3,133 | -2.13 | -47.87% |
Harvard Apparatus Regene... (QB) Description
| Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company's Cellframe technology combines the synthetic scaffold with tissue engineering and cell biology to create method of addressing organ damage. Its Cellframe technology stimulates the body's signaling pathways and natural healing process to regenerate and restore organ function. The company is developing organ implants as a platform of being used in the esophagus, trachea, and bronchi. Its implants are being advanced and tested in preclinical collaborative studies with Mayo Clinic and Connecticut Children's Medical Center. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2012 and is headquartered in Holliston, Massachusetts. |
